Jiufuyuan Biotechnology Company Limited (JFY)

JFY Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Revenue	7.14	7.14	4.86
Revenue Growth (YoY)	-	46.90%	-
Cost of Revenue	4.08	4.08	2.8
Gross Profit	3.06	3.06	2.06
Selling, General & Admin	1.95	1.95	1.38
Other Operating Expenses	-1.31	-1.31	-1.01
Operating Expenses	0.64	0.64	0.37
Operating Income	2.42	2.42	1.69
Other Expense / Income	1.75	1.75	1.26
Pretax Income	0.67	0.67	0.43
Net Income	0.67	0.67	0.43
Net Income Growth	-	54.39%	-
Free Cash Flow	0.16	0.16	-4.8
Gross Margin	42.87%	42.87%	42.46%
Operating Margin	33.93%	33.93%	34.76%
Profit Margin	9.36%	9.36%	8.91%
Free Cash Flow Margin	2.22%	2.22%	-98.66%
EBITDA	0.67	0.67	0.43
EBITDA Margin	9.36%	9.36%	8.91%
EBIT	0.67	0.67	0.43
EBIT Margin	9.36%	9.36%	8.91%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).